会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Novel penicillanic acid derivatives
    • Penicillansäure衍。
    • EP0148283A1
    • 1985-07-17
    • EP83112841.8
    • 1983-12-20
    • F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft
    • Wei, Chung-ChenWeigele, Manfred
    • C07D499/02C07D401/06C07D403/06A61K31/43A61K31/545
    • C07D231/12C07D211/18C07D211/34C07D233/56C07D249/08C07D401/04C07D401/06C07D403/06C07D499/00Y02P20/55
    • @ 6-Amidinopenicillanic acid derivatives wherein one of the nitrogen atoms of the amidino group is part of a heterocyclic ring having on a side chain an unsubstituted heterocyclic ring containing 2 to 3 nitrogen atoms, with formula:
      wherein n is 0 or 1;
      is a saturated 5 to 7 membered heterocyclic ring containing the nitrogen atom as the only heteroatom, said ring being unsubstituted or substituted in one or more positions with lower alkyl;
      is a 5 to 7 membered heterocyclic ring having at most one additional nitrogen atom, from 0 to 2 additional double bonds, and, aside from R, either being unsubstituted or substituted in one or more positions with lower alkyl; R is lower alkyl, nitro, hydrogen,-COOH,-(CH 2 ) y -NHR 4 ;-(CH 2 ) y -OR 3 and
      R 3 is hydrogen or lower alkyl, y is an integer from 0 to 4; R, is hydrogen, lower alkyl or an amino-protecting group, (Continuation next page) R 5 and R 6 are hydrogen or lower alkyl and R 7 is lower alkylene, hydrolyzable esters thereof, salts thereof and hydrates thereof, and with formula:
      wherein n is an integer from 0 to 1; R, is hydrogen or lower alkyl;
      is a saturated 5 to 7 membered heterocyclic ring containing the nitrogen atom as the only heteroatom, said ring being unsubstituted or substituted in one or more positions with lower alkyl;
      is a 5 to 7 membered heterocyclic ring containing no additional double bonds or can be additionally aromatic when it is 5 membered, said ring being either unsubstituted or substituted in one or more positions with lower alkyl; and R 7 is lower alkylene, hydrolyzable esters thereof, salts thereof and hydrates thereof.
      These compounds are useful as antibiotics.
    • 6-脒基青霉烷酸衍生物,其中脒基中的一个氮原子是在侧链上含有2至3个氮原子的未取代杂环的杂环的一部分,其中n为0或1; 是饱和的5至7元杂环,其含有氮原子作为唯一的杂原子,所述环是未取代的或在一个或多个位置被低级烷基取代; 是具有至多一个另外的氮原子,0至2个另外的双键的5至7元杂环,并且除R1之外未被取代或在一个或多个位置被低级烷基取代; R是低级烷基,硝基,氢,-COOH, - (CH2)y-NHR4; - (CH 2)y -OR 3和 R 3是氢或低级烷基,y是0至4的整数; R4为氢,低级烷基或氨基保护基,R5和R6为氢或低级烷基,R7为低级亚烷基,其可水解酯,其盐及其水合物,式为:其中n为 0到1; R1是氢或低级烷基; 是饱和的5至7元杂环,其含有氮原子作为唯一的杂原子,所述环是未取代的或在一个或多个位置被低级烷基取代; 是不含另外双键的5至7元杂环,或当其为5元时可另外为芳族,所述环为未取代的或在一个或多个位置被低级烷基取代; 并且R 7为低级亚烷基,其可水解酯,其盐及其水合物。 这些化合物可用作抗生素。
    • 3. 发明公开
    • Penicillin derivatives
    • 青霉素衍生物
    • EP0055099A1
    • 1982-06-30
    • EP81305957.3
    • 1981-12-18
    • ICI PHARMAIMPERIAL CHEMICAL INDUSTRIES PLC
    • Jung, Frédéric HenriDavies, Gareth Morse
    • C07D499/02A61K31/43
    • C07D499/00
    • A penicillin derivative of the formula I:
      in which R 1 is any one of the C-3 substituents from antibacterially-active penicillins known in the art; ⊕

      X is a nitrogen atom or a radical of the formula N-R 3 ; R 2 and R 3 , which may be the same or different, are hydrogen atoms or 1-6C alkyl, 1-6C alkanoyl, hydroxy, 1-6C alkoxy, amino, 1-6C alkanoylamino, 1-6C alkylamino, 1-6C aminoalkyl, 1-6C hydroxyalkyl, 2-6C carboxyalkyl, 2-6C alkenyl, 3-6C alkoxyalkyl, 3-8C alkoxycarbonylalkyl, furylmethyl, phenyl or 7-11 C phenylalkyl radicals, in the latter two of which the phenyl ring is optionally substituted by a halogen atom or by a methyl, methoxy, nitro, hydroxy, amino, carboxy or methoxycarbonyl radical;
      A in which R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are as described in the specification; and the pharmaceutically-acceptable acid- or base-addition salts thereof. Pharmaceutical compositions and manufacturing processes are also described.
    • 式I的青霉素衍生物:其中R1是来自本领域已知的抗细菌活性青霉素的C-3取代基中的任何一个; ⊕X是氮原子或式N-R3的基团; R2和R3可以相同或不同,为氢原子或1-6C烷基,1-6C烷酰基,羟基,1-6C烷氧基,氨基,1-6C烷酰基氨基,1-6C烷基氨基,1-6C氨基烷基, 1-6C羟基烷基,2-6C羧基烷基,2-6C链烯基,3-6C烷氧基烷基,3-8C烷氧基羰基烷基,呋喃基甲基,苯基或7-11C苯基烷基,后两个苯基环任选被 卤素原子或被甲基,甲氧基,硝基,羟基,氨基,羧基或甲氧基羰基取代; A是式II或III的基团:其中R 4,R 5,R 6,R 7,R 8和R 9如说明书中所述; 及其药学上可接受的酸或碱加成盐。 还描述了药物组合物和制造过程。